D-0330-2015 Class II Terminated
FDA drug recall D-0330-2015 was initiated by Aurobindo Pharma USA Inc on Oct 17, 2014 and is designated Class II. Reason for recall: Failed Tablet/Capsule Specifications: Complaints of empty capsules received. The recall status is terminated (terminated May 23, 2016). Affected quantity: 24,816 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 14, 2015
- Initiation Date
- Oct 17, 2014
- Termination Date
- May 23, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 24,816 bottles
Product description
Gabapentin Capsules, USP 300 mg, 100-count bottles, Rx only, Manufactured for: Northstar Rx LLC, Memphis, TN 38141; Manufactured by: Aurobindo Pharma Limited, Unit-VII (SEZ), Mahaboob Nagar (Dt), AP-509302, INDIA, NDC 16714-662-01, UPC 3 16714-662-01 5.
Reason for recall
Failed Tablet/Capsule Specifications: Complaints of empty capsules received.
Distribution pattern
Nationwide
Code information
Lot #: GESB14011-A, Exp 12/15
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0330-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026